APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Discovery Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Drug Discovery Software Market Outlook and Growth Opportunities 2026

30 January 2026198 pages

Choose your research edition.

Industry ResearchAI Drug Discovery Software Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Discovery Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI Drug Discovery Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Discovery Software Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Discovery Software Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global AI Drug Discovery Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Drug Discovery Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Drug Discovery Software market include Merck KGaA, Atomwise Inc, BenevolentAI, BullFrog AI, Genesis Therapeutics, Pharma.AI, Recursion Pharmaceuticals, Verge Genomics and Schrödinger, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Drug Discovery Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Drug Discovery Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Drug Discovery Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Drug Discovery Software market.

AI Drug Discovery Software Segment by Company

Merck KGaA

Atomwise Inc

BenevolentAI

BullFrog AI

Genesis Therapeutics

Pharma.AI

Recursion Pharmaceuticals

Verge Genomics

Schrödinger, Inc.

XtalPi

Iktos

AI Drug Discovery Software Segment by Type

Cloud Based

On Premise

AI Drug Discovery Software Segment by Application

CRO and Universities

Pharmaceutical Company

Test Lab

AI Drug Discovery Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Drug Discovery Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Drug Discovery Software key companies, revenue, market share, and recent developments.

3. To split the AI Drug Discovery Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Drug Discovery Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Drug Discovery Software significant trends, drivers, influence factors in global and regions.

6. To analyze AI Drug Discovery Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Discovery Software industry.

Chapter 3: Detailed analysis of AI Drug Discovery Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Drug Discovery Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Drug Discovery Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Drug Discovery Software Industry Trends Table 2. AI Drug Discovery Software Industry Drivers Table 3. AI Drug Discovery Software Industry Opportunities and Challenges Table 4. AI Drug Discovery Software Industry Restraints Table 5. Global AI Drug Discovery Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Drug Discovery Software Revenue Share by Company (2021-2026) Table 7. Global AI Drug Discovery Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Drug Discovery Software Key Company Manufacturing Base & Headquarters Table 9. Global AI Drug Discovery Software Company, Product Type & Application Table 10. Global AI Drug Discovery Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Drug Discovery Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud Based Table 15. Significant Companies of On Premise Table 16. Global AI Drug Discovery Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI Drug Discovery Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI Drug Discovery Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI Drug Discovery Software Sales Value Share by Type (2021-2026) Table 20. Global AI Drug Discovery Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of CRO and Universities Table 22. Significant Companies of Pharmaceutical Company Table 23. Significant Companies of Test Lab Table 24. Global AI Drug Discovery Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global AI Drug Discovery Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global AI Drug Discovery Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global AI Drug Discovery Software Sales Value Share by Application (2021-2026) Table 28. Global AI Drug Discovery Software Sales Value Share by Application (2027-2032) Table 29. Global AI Drug Discovery Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global AI Drug Discovery Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global AI Drug Discovery Software Sales Value Share by Region (2021-2026) Table 32. Global AI Drug Discovery Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global AI Drug Discovery Software Sales Value Share by Region (2027-2032) Table 34. Global AI Drug Discovery Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global AI Drug Discovery Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global AI Drug Discovery Software Sales Value Market Share by Country (2021-2026) Table 37. Global AI Drug Discovery Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global AI Drug Discovery Software Sales Value Market Share by Country (2027-2032) Table 39. Merck KGaA Company Information Table 40. Merck KGaA Business Overview Table 41. Merck KGaA AI Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Merck KGaA AI Drug Discovery Software Product Portfolio Table 43. Merck KGaA Recent Development Table 44. Atomwise Inc Company Information Table 45. Atomwise Inc Business Overview Table 46. Atomwise Inc AI Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Atomwise Inc AI Drug Discovery Software Product Portfolio Table 48. Atomwise Inc Recent Development Table 49. BenevolentAI Company Information Table 50. BenevolentAI Business Overview Table 51. BenevolentAI AI Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. BenevolentAI AI Drug Discovery Software Product Portfolio Table 53. BenevolentAI Recent Development Table 54. BullFrog AI Company Information Table 55. BullFrog AI Business Overview Table 56. BullFrog AI AI Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. BullFrog AI AI Drug Discovery Software Product Portfolio Table 58. BullFrog AI Recent Development Table 59. Genesis Therapeutics Company Information Table 60. Genesis Therapeutics Business Overview Table 61. Genesis Therapeutics AI Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Genesis Therapeutics AI Drug Discovery Software Product Portfolio Table 63. Genesis Therapeutics Recent Development Table 64. Pharma.AI Company Information Table 65. Pharma.AI Business Overview Table 66. Pharma.AI AI Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Pharma.AI AI Drug Discovery Software Product Portfolio Table 68. Pharma.AI Recent Development Table 69. Recursion Pharmaceuticals Company Information Table 70. Recursion Pharmaceuticals Business Overview Table 71. Recursion Pharmaceuticals AI Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Recursion Pharmaceuticals AI Drug Discovery Software Product Portfolio Table 73. Recursion Pharmaceuticals Recent Development Table 74. Verge Genomics Company Information Table 75. Verge Genomics Business Overview Table 76. Verge Genomics AI Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Verge Genomics AI Drug Discovery Software Product Portfolio Table 78. Verge Genomics Recent Development Table 79. Schrödinger, Inc. Company Information Table 80. Schrödinger, Inc. Business Overview Table 81. Schrödinger, Inc. AI Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Schrödinger, Inc. AI Drug Discovery Software Product Portfolio Table 83. Schrödinger, Inc. Recent Development Table 84. XtalPi Company Information Table 85. XtalPi Business Overview Table 86. XtalPi AI Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. XtalPi AI Drug Discovery Software Product Portfolio Table 88. XtalPi Recent Development Table 89. Iktos Company Information Table 90. Iktos Business Overview Table 91. Iktos AI Drug Discovery Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Iktos AI Drug Discovery Software Product Portfolio Table 93. Iktos Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. AI Drug Discovery Software Product Image Figure 2. Global AI Drug Discovery Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Drug Discovery Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud Based Image Figure 8. On Premise Image Figure 9. Global AI Drug Discovery Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI Drug Discovery Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI Drug Discovery Software Sales Value Share by Type (2021-2032) Figure 12. CRO and Universities Image Figure 13. Pharmaceutical Company Image Figure 14. Test Lab Image Figure 15. Global AI Drug Discovery Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global AI Drug Discovery Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global AI Drug Discovery Software Sales Value Share by Application (2021-2032) Figure 18. Global AI Drug Discovery Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global AI Drug Discovery Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America AI Drug Discovery Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America AI Drug Discovery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe AI Drug Discovery Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe AI Drug Discovery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific AI Drug Discovery Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific AI Drug Discovery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America AI Drug Discovery Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America AI Drug Discovery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa AI Drug Discovery Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa AI Drug Discovery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt AI Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud Based
  • On Premise
Applications
  • CRO and Universities
  • Pharmaceutical Company
  • Test Lab
Companies covered
  • Merck KGaA
  • Atomwise Inc
  • BenevolentAI
  • BullFrog AI
  • Genesis Therapeutics
  • Pharma.AI
  • Recursion Pharmaceuticals
  • Verge Genomics
  • Schrödinger, Inc.
  • XtalPi
  • Iktos

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Drug Discovery Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Drug Discovery Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Drug Discovery Software Market Dynamics
  1. 2.1 AI Drug Discovery Software Industry Trends
  2. 2.2 AI Drug Discovery Software Industry Drivers
  3. 2.3 AI Drug Discovery Software Industry Opportunities and Challenges
  4. 2.4 AI Drug Discovery Software Industry Restraints
3 AI Drug Discovery Software Market by Company
  1. 3.1 Global AI Drug Discovery Software Company Revenue Ranking in 2025
  2. 3.2 Global AI Drug Discovery Software Revenue by Company (2021-2026)
  3. 3.3 Global AI Drug Discovery Software Company Ranking (2024-2026)
  4. 3.4 Global AI Drug Discovery Software Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Drug Discovery Software Company Product Type and Application
  6. 3.6 Global AI Drug Discovery Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Drug Discovery Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Drug Discovery Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Drug Discovery Software Market by Type
  1. 4.1 AI Drug Discovery Software Type Introduction
  2. 4.1.1 Cloud Based
  3. 4.1.2 On Premise
  4. 4.2 Global AI Drug Discovery Software Sales Value by Type
  5. 4.2.1 Global AI Drug Discovery Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI Drug Discovery Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI Drug Discovery Software Sales Value Share by Type (2021-2032)
5 AI Drug Discovery Software Market by Application
  1. 5.1 AI Drug Discovery Software Application Introduction
  2. 5.1.1 CRO and Universities
  3. 5.1.2 Pharmaceutical Company
  4. 5.1.3 Test Lab
  5. 5.2 Global AI Drug Discovery Software Sales Value by Application
  6. 5.2.1 Global AI Drug Discovery Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global AI Drug Discovery Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global AI Drug Discovery Software Sales Value Share by Application (2021-2032)
6 AI Drug Discovery Software Regional Value Analysis
  1. 6.1 Global AI Drug Discovery Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Drug Discovery Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Drug Discovery Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Drug Discovery Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Drug Discovery Software Sales Value (2021-2032)
  7. 6.3.2 North America AI Drug Discovery Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Drug Discovery Software Sales Value (2021-2032)
  10. 6.4.2 Europe AI Drug Discovery Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Drug Discovery Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Drug Discovery Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Drug Discovery Software Sales Value (2021-2032)
  16. 6.6.2 South America AI Drug Discovery Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Drug Discovery Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Drug Discovery Software Sales Value Share by Country, 2025 VS 2032
7 AI Drug Discovery Software Country-level Value Analysis
  1. 7.1 Global AI Drug Discovery Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Drug Discovery Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Drug Discovery Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Drug Discovery Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Drug Discovery Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck KGaA
  2. 8.1.1 Merck KGaA Company Information
  3. 8.1.2 Merck KGaA Business Overview
  4. 8.1.3 Merck KGaA AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck KGaA AI Drug Discovery Software Product Portfolio
  6. 8.1.5 Merck KGaA Recent Developments
  7. 8.2 Atomwise Inc
  8. 8.2.1 Atomwise Inc Company Information
  9. 8.2.2 Atomwise Inc Business Overview
  10. 8.2.3 Atomwise Inc AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Atomwise Inc AI Drug Discovery Software Product Portfolio
  12. 8.2.5 Atomwise Inc Recent Developments
  13. 8.3 BenevolentAI
  14. 8.3.1 BenevolentAI Company Information
  15. 8.3.2 BenevolentAI Business Overview
  16. 8.3.3 BenevolentAI AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BenevolentAI AI Drug Discovery Software Product Portfolio
  18. 8.3.5 BenevolentAI Recent Developments
  19. 8.4 BullFrog AI
  20. 8.4.1 BullFrog AI Company Information
  21. 8.4.2 BullFrog AI Business Overview
  22. 8.4.3 BullFrog AI AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BullFrog AI AI Drug Discovery Software Product Portfolio
  24. 8.4.5 BullFrog AI Recent Developments
  25. 8.5 Genesis Therapeutics
  26. 8.5.1 Genesis Therapeutics Company Information
  27. 8.5.2 Genesis Therapeutics Business Overview
  28. 8.5.3 Genesis Therapeutics AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Genesis Therapeutics AI Drug Discovery Software Product Portfolio
  30. 8.5.5 Genesis Therapeutics Recent Developments
  31. 8.6 Pharma.AI
  32. 8.6.1 Pharma.AI Company Information
  33. 8.6.2 Pharma.AI Business Overview
  34. 8.6.3 Pharma.AI AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pharma.AI AI Drug Discovery Software Product Portfolio
  36. 8.6.5 Pharma.AI Recent Developments
  37. 8.7 Recursion Pharmaceuticals
  38. 8.7.1 Recursion Pharmaceuticals Company Information
  39. 8.7.2 Recursion Pharmaceuticals Business Overview
  40. 8.7.3 Recursion Pharmaceuticals AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Recursion Pharmaceuticals AI Drug Discovery Software Product Portfolio
  42. 8.7.5 Recursion Pharmaceuticals Recent Developments
  43. 8.8 Verge Genomics
  44. 8.8.1 Verge Genomics Company Information
  45. 8.8.2 Verge Genomics Business Overview
  46. 8.8.3 Verge Genomics AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Verge Genomics AI Drug Discovery Software Product Portfolio
  48. 8.8.5 Verge Genomics Recent Developments
  49. 8.9 Schrödinger, Inc.
  50. 8.9.1 Schrödinger, Inc. Company Information
  51. 8.9.2 Schrödinger, Inc. Business Overview
  52. 8.9.3 Schrödinger, Inc. AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Schrödinger, Inc. AI Drug Discovery Software Product Portfolio
  54. 8.9.5 Schrödinger, Inc. Recent Developments
  55. 8.10 XtalPi
  56. 8.10.1 XtalPi Company Information
  57. 8.10.2 XtalPi Business Overview
  58. 8.10.3 XtalPi AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 XtalPi AI Drug Discovery Software Product Portfolio
  60. 8.10.5 XtalPi Recent Developments
  61. 8.11 Iktos
  62. 8.11.1 Iktos Company Information
  63. 8.11.2 Iktos Business Overview
  64. 8.11.3 Iktos AI Drug Discovery Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Iktos AI Drug Discovery Software Product Portfolio
  66. 8.11.5 Iktos Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst